Provided by Tiger Trade Technology Pte. Ltd.

LivaNova PLC

78.26
-0.4800-0.61%
Pre-market: 79.160.9007+1.15%04:14 EDT
Volume:823.21K
Turnover:64.62M
Market Cap:4.30B
PE:23.09
High:80.00
Open:78.65
Low:78.00
Close:78.74
52wk High:85.76
52wk Low:48.82
Shares:54.93M
Float Shares:54.68M
Volume Ratio:1.70
T/O Rate:1.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.39
EPS(LYR):-4.4500
ROE:15.40%
ROA:5.23%
PB:3.24
PE(LYR):-17.59

Loading ...

LivaNova Chief Innovation Officer Ahmet Tezel Disposes of Shares Worth $435,409.36

Reuters
·
Aug 14

iRhythm Q2 Revenue Beats Estimates on Sustained Volume Demand, Lifts FY Guidance

Reuters
·
Aug 07

Pulse Biosciences Q2 Net Loss Widens, Cash Position Strengthens

Reuters
·
Aug 07

LivaNova PLC Lifts Guidance on Record Q2 Results

TIPRANKS
·
Aug 06

Nyxoah Q2 Revenue Surges on U.S. Growth, but Margins Drop

Reuters
·
Aug 06

LivaNova is Maintained at Buy by Needham

Dow Jones
·
Aug 06

LivaNova PLC Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

Compass Pathways' Q2 Loss Widens on Commercial Readiness Activity Costs

Reuters
·
Aug 05

LivaNova Q2 2026 Earnings: Revenue Growth Lifts Guidance

TradingKey
·
Aug 05

LivaNova Q2 FY26 GAAP Diluted EPS Rises to $1.93; Revenue Increases 10.8% Year over Year to $390.6 Million

Reuters
·
Aug 05

GUIDANCE: (LIVN) LivaNova Expects 2026 Adjusted EPS Range $4.30 to $4.40, vs. FactSet Est of $4.25

MT Newswires Live
·
Aug 05

UK's LivaNova Q2 Revenue Beats Estimates; Lifts 2026 Outlook

Reuters
·
Aug 05

LivaNova Says Cardiopulmonary President Stefano Folli Files Initial Beneficial Ownership Statement

Reuters
·
Aug 05

LivaNova Q2 Adjusted EPS USD 1.26 Vs. IBES Estimate USD 1.1

Reuters
·
Aug 05

LivaNova Q2 Adj. EPS $1.26 Beats $1.10 Estimate, Sales $390.600M Beat $380.758M Estimate

Benzinga Earnings
·
Aug 05

LivaNova: Deal Expected to Support Increased Oxygenator Output over Time, Strengthening Co Ability to Satisfy Unmet Customer Demand

THOMSON REUTERS
·
Aug 05

LivaNova Outlook FY Revenue Growth 8-9%

THOMSON REUTERS
·
Aug 05

LivaNova Outlook FY Adjusted Free Cash Flow USD 140-160 Million

THOMSON REUTERS
·
Aug 05

LivaNova - Enters Long-Term Agreement with Thermo Fisher Scientific for Oxygenator Component Supply

THOMSON REUTERS
·
Aug 05

LivaNova Plc: Announce Agreement with Thermo Fisher Scientific

THOMSON REUTERS
·
Aug 05